Aurinia Pharmaceuticals (AUPH) Reports In-Line Q1 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Aurinia Pharmaceuticals (AUPH) Reports In-Line Q1 EPS

Aurinia Reports First Quarter 2020 Financial Results and Recent Operational Highlights

May 14, 2020 4:02 PM EDT

- Cash and cash equivalents totaled approximately $286 million at March 31, 2020 -

- Rolling submission of voclosporin New Drug Application to the U.S. Food & Drug Administration remains on track for completion by the end of the second quarter 2020

- Continued evolution into commercial-stage organization highlighted by the appointments of Timothy P Walbert to the Board, Max Colao as Chief Commercial Officer, and Joe Miller as Chief Financial Officer

- Conference call and webcast to be hosted today at 4:30pm EDT -

VICTORIA, British... More